BAKER & HOSTETLER LLP

Lobbying for FERRING PHARMACEUTICALS, INC. · Biopharmaceutical company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income · posted Apr 19, 2026

Lobbying activity 1

Health Issues

Regulatory and reimbursement policy issues related to federal healthcare programs associated with gene therapy, IVF therapy and oncology treatments.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.